NCT03088410View on ClinicalTrials.gov

Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana

PHASE4CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

August 22, 2016

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
HIVInsulin SensitivityDiabetes Mellitus
Interventions
DRUG

Zidovudine

neonatal 4 weeks prophylactic

DRUG

Nevirapine

neonatal 4 weeks prophylactic

Trial Locations (1)

Unknown

Botswana-Harvard AIDS Institute Partnership, Gaborone

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT03088410 - Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana | Biotech Hunter | Biotech Hunter